Anti-inhibitor coagulant complex Not Yet Recruiting Phase 3 Trials for Hemophilia A Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04563520SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis